Variant report

Variant	rs4711143
Chromosome Location	chr6:27173399-27173400
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:27171643..27174637-chr6:27189780..27192131,2	K562	blood:
2	chr6:27172666..27175265-chr6:27265465..27267285,2	K562	blood:
3	chr6:27171746..27174029-chr6:27180862..27184062,3	K562	blood:
4	chr6:27164367..27166691-chr6:27171692..27173483,2	MCF-7	breast:
5	chr6:27113325..27119101-chr6:27172973..27177922,8	K562	blood:
6	chr6:27172465..27174162-chr6:27404075..27406458,2	K562	blood:
7	chr6:27170157..27172532-chr6:27173101..27175252,2	MCF-7	breast:
8	chr6:27162610..27164330-chr6:27172522..27175063,2	K562	blood:
9	chr6:27164413..27166775-chr6:27172734..27175506,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000197903	Chromatin interaction
ENSG00000265565	Chromatin interaction
ENSG00000184825	Chromatin interaction

Extended variants
information (count: 31 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:30)

rs_ID	r²[population]
rs11964003	0.92[JPT][hapmap]
rs13437191	0.86[JPT][hapmap]
rs13437532	0.88[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.97[LWK][hapmap];1.00[MEX][hapmap];0.94[YRI][hapmap];0.84[AFR][1000 genomes];0.93[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs16897467	1.00[CEU][hapmap]
rs2393918	1.00[CEU][hapmap]
rs36043209	0.85[EUR][1000 genomes]
rs3800311	0.87[JPT][hapmap]
rs3800312	0.87[JPT][hapmap]
rs3800313	0.87[JPT][hapmap]
rs3800317	1.00[CEU][hapmap]
rs41473150	1.00[CEU][hapmap]
rs4582379	1.00[CEU][hapmap]
rs4713078	0.93[EUR][1000 genomes]
rs5030960	0.87[JPT][hapmap]
rs6906761	0.93[JPT][hapmap]
rs6912503	0.87[JPT][hapmap]
rs6922098	1.00[CEU][hapmap];1.00[TSI][hapmap]
rs6932243	0.93[JPT][hapmap]
rs7755577	0.93[JPT][hapmap]
rs7760996	0.89[AFR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs9348754	0.85[AMR][1000 genomes]
rs9366683	1.00[CEU][hapmap]
rs9368488	1.00[CEU][hapmap];1.00[TSI][hapmap]
rs9379957	1.00[CEU][hapmap]
rs9461340	0.86[JPT][hapmap]
rs9461342	0.93[AFR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs9468006	0.91[JPT][hapmap]
rs9468014	0.87[JPT][hapmap]
rs9468060	1.00[CEU][hapmap]
rs994690	1.00[CEU][hapmap];1.00[TSI][hapmap]

Variant overlapped rSNPs/rCNVs (count:1 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv948921	chr6:26556890-27443957	Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	472 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:31 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:27173000-27173400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
2	chr6:27173000-27173400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr6:27173000-27173400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr6:27173000-27173400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr6:27173000-27173600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
6	chr6:27173000-27174000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
7	chr6:27173000-27174200	Active TSS	H1 Cell Line	embryonic stem cell
8	chr6:27173000-27174200	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
9	chr6:27173200-27173400	Flanking Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
10	chr6:27173200-27173400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
11	chr6:27173200-27173400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
12	chr6:27173200-27173400	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr6:27173200-27173400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
14	chr6:27173200-27173400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr6:27173200-27173400	Bivalent Enhancer	Thymus	Thymus
16	chr6:27173200-27173600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
17	chr6:27173200-27173600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
18	chr6:27173200-27173800	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr6:27173200-27173800	Enhancers	Placenta Amnion	Placenta Amnion
20	chr6:27173200-27173800	Flanking Active TSS	K562	blood
21	chr6:27173200-27173800	Bivalent/Poised TSS	NHEK	skin
22	chr6:27173200-27174000	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr6:27173200-27174200	Active TSS	ES-I3 Cell Line	embryonic stem cell
24	chr6:27173200-27174200	Active TSS	H9 Cell Line	embryonic stem cell
25	chr6:27173200-27174200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr6:27173200-27174200	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr6:27173200-27174200	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr6:27173200-27174400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
29	chr6:27173200-27174400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
30	chr6:27173200-27174400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
31	chr6:27173200-27174600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links